Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,092 | 3 | 68.1% |
| Unspecified | $1,200 | 1 | 16.1% |
| Travel and Lodging | $751.49 | 5 | 10.1% |
| Food and Beverage | $431.86 | 9 | 5.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC | $6,045 | 4 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $681.33 | 6 | $0 (2019) |
| C. R. Bard, Inc. & Subsidiaries | $341.67 | 1 | $0 (2020) |
| Blue Earth Diagnostics Limited | $146.38 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $109.73 | 2 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $109.36 | 1 | $0 (2017) |
| Medtronic, Inc. | $28.62 | 1 | $0 (2024) |
| DENTSPLY IH Inc. | $12.73 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $928.62 | 2 | IRONWOOD PHARMACEUTICALS, INC ($900.00) |
| 2023 | $1,200 | 1 | Ironwood Pharmaceuticals, Inc ($1,200) |
| 2022 | $4,135 | 5 | Ironwood Pharmaceuticals, Inc ($3,945) |
| 2020 | $341.67 | 1 | C. R. Bard, Inc. & Subsidiaries ($341.67) |
| 2019 | $694.06 | 7 | PROCEPT BioRobotics Corporation ($681.33) |
| 2017 | $175.93 | 2 | Endo Pharmaceuticals Inc. ($109.36) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2024 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Surgical Stapling | ||||||
| 01/03/2024 | IRONWOOD PHARMACEUTICALS, INC | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 05/24/2023 | Ironwood Pharmaceuticals, Inc | — | — | Cash or cash equivalent | $1,200.00 | Research |
| Study: C3300-201 | ||||||
| 05/16/2022 | Ironwood Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| 05/16/2022 | Ironwood Pharmaceuticals, Inc | — | Travel and Lodging | Cash or cash equivalent | $95.20 | General |
| 05/15/2022 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $123.26 | General |
| Category: Diagnostic Imaging | ||||||
| 05/15/2022 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Diagnostic Imaging | ||||||
| 05/14/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $43.16 | General |
| Category: Oncology | ||||||
| 10/23/2020 | C. R. Bard, Inc. & Subsidiaries | — | Consulting Fee | Cash or cash equivalent | $341.67 | General |
| 07/01/2019 | DENTSPLY IH Inc. | LoFric (Device) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Medical Urology | ||||||
| 04/04/2019 | PROCEPT BioRobotics Corporation | AquaBeam Robotic System (Device) | Travel and Lodging | Cash or cash equivalent | $321.35 | General |
| Category: Urology | ||||||
| 04/04/2019 | PROCEPT BioRobotics Corporation | AquaBeam Robotic System (Device) | Travel and Lodging | Cash or cash equivalent | $29.64 | General |
| Category: Urology | ||||||
| 03/22/2019 | PROCEPT BioRobotics Corporation | AquaBeam Robotic System (Device) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Urology | ||||||
| 03/22/2019 | PROCEPT BioRobotics Corporation | AquaBeam Robotic System (Device) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Urology | ||||||
| 03/21/2019 | PROCEPT BioRobotics Corporation | AquaBeam Robotic System (Device) | Travel and Lodging | In-kind items and services | $276.30 | General |
| Category: Urology | ||||||
| 03/21/2019 | PROCEPT BioRobotics Corporation | AquaBeam Robotic System (Device) | Travel and Lodging | In-kind items and services | $29.00 | General |
| Category: Urology | ||||||
| 12/07/2017 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $109.36 | General |
| Category: UROLOGY | ||||||
| 09/08/2017 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $66.57 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| C3300-201 | Ironwood Pharmaceuticals, Inc | $1,200 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 47 | 48 | $22,154 | $4,312 |
| 2021 | 9 | 890 | 977 | $394,538 | $72,011 |
| 2020 | 13 | 1,002 | 1,096 | $442,898 | $70,228 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 26 | $13,864 | $2,672 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 22 | $8,290 | $1,641 | 19.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 318 | 371 | $122,325 | $27,616 | 22.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 135 | 149 | $69,670 | $15,616 | 22.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 60 | 68 | $63,680 | $14,006 | 22.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 55 | 55 | $24,859 | $5,161 | 20.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 27 | $16,701 | $3,943 | 23.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $10,245 | $1,721 | 16.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 141 | 151 | $34,126 | $1,407 | 4.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 34 | 34 | $6,922 | $1,316 | 19.0% |
| 51741 | Electronic assessment of bladder emptying | Office | 2021 | 105 | 107 | $46,010 | $1,224 | 2.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 331 | 382 | $117,610 | $21,884 | 18.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 147 | 160 | $71,801 | $13,790 | 19.2% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 57 | 67 | $55,861 | $11,942 | 21.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 66 | 66 | $29,532 | $5,675 | 19.2% |
| 51728 | Insertion of electronic device into bladder with voiding pressure studies | Office | 2020 | 12 | 12 | $17,836 | $3,987 | 22.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 33 | $19,705 | $3,604 | 18.3% |
| 52005 | Insertion of catheter into urinary duct (ureter) using an endoscope | Facility | 2020 | 17 | 17 | $13,889 | $1,888 | 13.6% |
| 51797 | Insertion of device into the abdomen with measurement of pressure and urine flow rate | Office | 2020 | 12 | 12 | $12,876 | $1,848 | 14.4% |
| 54235 | Injection procedure to induce erection | Office | 2020 | 20 | 20 | $7,475 | $1,508 | 20.2% |
| 51741 | Electronic assessment of bladder emptying | Office | 2020 | 121 | 132 | $56,330 | $1,390 | 2.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 145 | 154 | $25,604 | $1,301 | 5.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 30 | 30 | $5,700 | $1,072 | 18.8% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2020 | 11 | 11 | $8,679 | $340.64 | 3.9% |
About Dr. Michael Oleary, MD
Dr. Michael Oleary, MD is a Urology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124079660.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Oleary, MD has received a total of $7,475 in payments from pharmaceutical and medical device companies, with $928.62 received in 2024. These payments were reported across 18 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($5,092).
As a Medicare-enrolled provider, Oleary has provided services to 1,939 Medicare beneficiaries, totaling 2,121 services with total Medicare billing of $146,552. Data is available for 3 years (2020–2022), covering 24 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Boston, MA
- Active Since 05/12/2006
- Last Updated 05/30/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1124079660
Products in Payments
- AquaBeam Robotic System (Device) $681.33
- Axumin (Drug) $146.38
- XIAFLEX (Biological) $109.36
- Xtandi (Drug) $43.16
- SIGNIA (Device) $28.62
- LoFric (Device) $12.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Boston
Dr. Christopher Cutie, Md, MD
Urology — Payments: $3.8M
Brian Eisner, Md, MD
Urology — Payments: $594,130
Tony Luongo, Md, MD
Urology — Payments: $531,062
Dr. Shahin Tabatabaei, Md, MD
Urology — Payments: $165,699
Ricardo Munarriz, M.d, M.D
Urology — Payments: $138,151
Richard Babayan, M.d, M.D
Urology — Payments: $115,932